PT Medikaloka Hermina Tbk (ISX:HEAL) Retained Earnings: Rp3,104,018 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:HEAL PT Medikaloka Hermina Tbk ISX:HEAL
66 GF Score
Price Rp660.00
GF Value Rp1,576.58
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is PT Medikaloka Hermina Tbk Retained Earnings?

PT Medikaloka Hermina Tbk ISX:HEAL -2.94% 66 Retained Earnings is Rp3,104,018 Mil as of Jun. 2026. GuruFocus rates ISX:HEAL with a GF Score™ of 66/100 and a GF Value™ of Rp1,576.58 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. PT Medikaloka Hermina Tbk's retained earnings for the quarter that ended in Jun. 2026 was Rp3,104,018 Mil.

PT Medikaloka Hermina Tbk's quarterly retained earnings increased from Dec. 2025 (Rp3,130,657 Mil) to Mar. 2026 (Rp3,231,919 Mil) but then declined from Mar. 2026 (Rp3,231,919 Mil) to Jun. 2026 (Rp3,104,018 Mil).

PT Medikaloka Hermina Tbk's annual retained earnings increased from Dec. 2023 (Rp2,420,115 Mil) to Dec. 2024 (Rp2,826,686 Mil) and increased from Dec. 2024 (Rp2,826,686 Mil) to Dec. 2025 (Rp3,130,657 Mil).


PT Medikaloka Hermina Tbk  (ISX:HEAL) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


PT Medikaloka Hermina Tbk Retained Earnings Historical Data

* Premium members only.

The historical data trend for PT Medikaloka Hermina Tbk's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Medikaloka Hermina Tbk Retained Earnings Chart

PT Medikaloka Hermina Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,882,764.00 2,090,976.00 2,420,115.00 2,826,686.00 3,130,657.00

PT Medikaloka Hermina Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,923,185.00 3,054,355.00 3,130,657.00 3,231,919.00 3,104,018.00
ISX:HEAL
66GF Score
PT Medikaloka Hermina Tbk ISX:HEAL
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Medikaloka Hermina Tbk Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of Rp3,104,018 Mil mean?
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Retained Earnings of Rp3,104,018 Mil as of Jun. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on PT Medikaloka Hermina Tbk and its competitors.
Is PT Medikaloka Hermina Tbk's Retained Earnings too high?
PT Medikaloka Hermina Tbk's current Retained Earnings is Rp3,104,018 Mil. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Retained Earnings compare to HCA and THC?
PT Medikaloka Hermina Tbk's Retained Earnings of Rp3,104,018 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Healthcare Providers & Services company?
A good Retained Earnings depends on the Healthcare Providers & Services industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on PT Medikaloka Hermina Tbk and its competitors. PT Medikaloka Hermina Tbk's current Retained Earnings is Rp3,104,018 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,576.58, compared to a current price of Rp660.00 — trading 58.1% below its estimated fair value. The current Retained Earnings is Rp3,104,018 Mil. PT Medikaloka Hermina Tbk's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Retained Earnings is Rp3,104,018 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?

Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued. The current stock price of Rp660.00 is trading 58.1% below its estimated GF Value™ of Rp1,576.58. GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.

Key valuation signals for ISX:HEAL:

  • Retained Earnings: Rp3,104,018 Mil
  • GF Value™: Rp1,576.58 vs. price of Rp660.00 (58.1% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Medikaloka Hermina Tbk Business Description

Address Jalan Selangit B-10 Kavling No. 4, Hermina Tower, Kemayoran, Jakarta, IDN, 10610
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
66GF Score

Get the complete analysis for ISX:HEAL

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp660.00
Price
Rp1,576.58
GF Value